Influence of <i>KRAS</i> mutation status in metachronous and synchronous metastatic colorectal adenocarcinoma

Abstract

In this study, KRAS mutation status did not influence overall survival in either synchronous or metachronous metastatic colorectal adenocarcinoma and, as such, had no prognostic role in this disease setting.